Critical Path Public Private Partnerships Clinical Trials Optional
Funding Amount
$20,000,000 - $20,000,000
Deadline
Forecast — dates not yet posted
Number of Awards
1
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Critical Path Institute
Overview
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act . This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.
Details
- Agency: Food and Drug Administration
- Department: Department of Health and Human Services
- Opportunity #: FOR-FD-24-012
- Expected Awards: 1
- Instrument: cooperative_agreement;grant
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
Amount
Up to $250,000
Deadline
January 29, 2027
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration
Amount
Up to $200,000
Deadline
April 1, 2027
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration
Amount
Up to $300,000
Deadline
April 1, 2027
Laboratory Flexible Funding Model (LFFM)
Food and Drug Administration
Amount
Up to $1,500,000
Deadline
January 11, 2028
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Amount
Up to $600,000
Deadline
February 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration
Amount
Up to $1,250,000
Deadline
May 12, 2028
Ready to apply for Critical Path Public Private Partnerships Clinical Trials Optional?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Critical Path Public Private Partnerships Clinical Trials Optional. Now let's win it.